These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31707827)

  • 41. Ischemia-induced regional wall motion abnormality is improved after coronary angioplasty: demonstration by dobutamine stress echocardiography.
    Akosah KO; Porter TR; Simon R; Funai JT; Minisi AJ; Mohanty PK
    J Am Coll Cardiol; 1993 Mar; 21(3):584-9. PubMed ID: 8436738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris.
    Shkolnik E; Burneikaite G; Jakutis G; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Vasyuk Y; Laucevicius A; Celutkiene J
    Coron Artery Dis; 2018 Nov; 29(7):579-586. PubMed ID: 29912782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional and prognostic significance of silent ischemia during dobutamine stress echocardiography in the elderly.
    Bonou M; Benroubis A; Kranidis A; Antonellis I; Papakyriakos I; Harbis P; Anthopoulos L
    Coron Artery Dis; 2001 Sep; 12(6):499-506. PubMed ID: 11696689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low yield of stress imaging in a population-based study of asymptomatic patients after percutaneous coronary intervention.
    Peterson T; Askew JW; Bell M; Crusan D; Hodge D; Gibbons RJ
    Circ Cardiovasc Imaging; 2014 May; 7(3):438-45. PubMed ID: 24687040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Left ventricular transient ischemic dilation during dobutamine stress echocardiography predicts multi-vessel coronary artery disease.
    el-Mahalawy N; Abdel-Salam Z; Samir A; Mohasseb W; Nammas W
    J Cardiol; 2009 Oct; 54(2):255-61. PubMed ID: 19782263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests.
    Beleslin BD; Ostojic M; Stepanovic J; Djordjevic-Dikic A; Stojkovic S; Nedeljkovic M; Stankovic G; Petrasinovic Z; Gojkovic L; Vasiljevic-Pokrajcic Z
    Circulation; 1994 Sep; 90(3):1168-76. PubMed ID: 7916274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
    Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
    Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Hyperemic Impedance Echocardiography with Dobutamine Stress Echocardiography to Detect Inducible Myocardial Ischemia: A Pilot Study.
    Patel JJ; Gupta A; Nanda NC
    Echocardiography; 2016 Mar; 33(3):416-20. PubMed ID: 26932721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
    Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
    BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry.
    Holroyd EW; Sirker A; Kwok CS; Kontopantelis E; Ludman PF; De Belder MA; Butler R; Cotton J; Zaman A; Mamas MA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1283-1292. PubMed ID: 28683933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease.
    deFilippi CR; Willett DL; Irani WN; Eichhorn EJ; Velasco CE; Grayburn PA
    Circulation; 1995 Nov; 92(10):2863-8. PubMed ID: 7586253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
    Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
    BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Leap Forward for Ischemia-Guided Revascularization: Stress Echocardiography Predicts Angina Benefit With Percutaneous Coronary Intervention.
    Shaw LJ; Reynolds HR; Picard MH
    Circulation; 2019 Dec; 140(24):1981-1983. PubMed ID: 31707830
    [No Abstract]   [Full Text] [Related]  

  • 56. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
    Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultra-early risk stratification after myocardial infarction via pharmacological stress echocardiography: the relative value of resting function, viability and myocardial ischemia.
    Sclavo M; Aruta E; Presbitero P
    G Ital Cardiol; 1997 Oct; 27(10):1000-7. PubMed ID: 9359049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
    Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
    Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of visualization of successful revascularization on chest pain and quality of life in chronic coronary syndrome: study protocol for the multi-center, randomized, controlled PLA-pCi-EBO-pilot-trial.
    Wester M; Koll F; Zeman F; Dempfle A; Koller M; Frey N; Maier LS; Sossalla S
    Trials; 2020 Oct; 21(1):838. PubMed ID: 33032655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
    Sotomi Y; Onuma Y; Cavalcante R; Ahn JM; Lee CW; van Klaveren D; de Winter RJ; Wykrzykowska JJ; Farooq V; Morice MC; Steyerberg EW; Park SJ; Serruys PW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.